Company · Private
Altrartis Therapeutics Inc.
Key figures
- SEC number
- 2157050
Source: SEC EDGAR filings and company facts; checked 23 Oct 2026
About
Early-stage pharmaceutical company in New York that holds pending US patent applications on MDMA-related compounds.
Rounds and raises
22 Oct 2026
Form D: $11M sold of $11M offered, Other SEC
Source: SEC EDGAR Form D and the linked articles. All raises this week
With a free account
A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.